Functional Characterization of the New 8Q21 Asthma Risk Locus
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Role of Tomm40'523 – Apoe Haplotypes in Alzheimer's Disease Etiology
ROLE OF TOMM40’523 – APOE HAPLOTYPES IN ALZHEIMER’S DISEASE ETIOLOGY – FROM CLINICS TO MITOCHONDRIA RÈMY CARDOSO Tese para obtenção do grau de Doutor em EnvelHecimento e Doenças Crónicas Doutoramento em associação entre: Universidade NOVA de Lisboa (Faculdade de Ciências Médicas | NOVA Medical ScHool - FCM|NMS/UNL) Universidade de Coimbra (Faculdade de Medicina - FM/UC) Universidade do MinHo (Escola de Medicina - EMed/UM) Novembro, 2020 ROLE OF TOMM40’523 – APOE HAPLOTYPES IN ALZHEIMER’S DISEASE ETIOLOGY – FROM CLINICS TO MITOCHONDRIA Rèmy Cardoso Professora Doutora Catarina Resende Oliveira, Professora Catedrática Jubilada da FM/UC Professor Doutor Duarte Barral, Professor Associado da FCM|NMS/UNL Tese para obtenção do grau de Doutor em EnvelHecimento e Doenças Crónicas Doutoramento em associação entre: Universidade NOVA de Lisboa (Faculdade de Ciências Médicas | NOVA Medical ScHool - FCM|NMS/UNL) Universidade de Coimbra (Faculdade de Medicina - FM/UC) Universidade do MinHo (Escola de Medicina - EMed/UM) Novembro, 2020 This thesis was conducted at the Center for Neuroscience and Cell Biology (CNC.CIBB) of University of Coimbra and Coimbra University Hospital (CHUC) and was a collaboration of the following laboratories and departments with the supervision of Catarina Resende Oliveira MD, PhD, Full Professor of FM/UC and the co-supervision of Duarte Barral PhD, Associated professor of Nova Medical School, Universidade Nova de Lisboa: • Neurogenetics laboratory (CNC.CIBB) headed by Maria Rosário Almeida PhD • Neurochemistry laboratory (CHUC) -
Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
Leukemia (2010) 24, 756–764 & 2010 Macmillan Publishers Limited All rights reserved 0887-6924/10 $32.00 www.nature.com/leu ORIGINAL ARTICLE Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells A Pellagatti1, M Cazzola2, A Giagounidis3, J Perry1, L Malcovati2, MG Della Porta2,MJa¨dersten4, S Killick5, A Verma6, CJ Norbury7, E Hellstro¨m-Lindberg4, JS Wainscoat1 and J Boultwood1 1LRF Molecular Haematology Unit, NDCLS, John Radcliffe Hospital, Oxford, UK; 2Department of Hematology Oncology, University of Pavia Medical School, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; 3Medizinische Klinik II, St Johannes Hospital, Duisburg, Germany; 4Division of Hematology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; 5Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK; 6Albert Einstein College of Medicine, Bronx, NY, USA and 7Sir William Dunn School of Pathology, University of Oxford, Oxford, UK To gain insight into the molecular pathogenesis of the the World Health Organization.6,7 Patients with refractory myelodysplastic syndromes (MDS), we performed global gene anemia (RA) with or without ringed sideroblasts, according to expression profiling and pathway analysis on the hemato- poietic stem cells (HSC) of 183 MDS patients as compared with the the French–American–British classification, were subdivided HSC of 17 healthy controls. The most significantly deregulated based on the presence or absence of multilineage dysplasia. In pathways in MDS include interferon signaling, thrombopoietin addition, patients with RA with excess blasts (RAEB) were signaling and the Wnt pathways. Among the most signifi- subdivided into two categories, RAEB1 and RAEB2, based on the cantly deregulated gene pathways in early MDS are immuno- percentage of bone marrow blasts. -
Establishing the Pathogenicity of Novel Mitochondrial DNA Sequence Variations: a Cell and Molecular Biology Approach
Mafalda Rita Avó Bacalhau Establishing the Pathogenicity of Novel Mitochondrial DNA Sequence Variations: a Cell and Molecular Biology Approach Tese de doutoramento do Programa de Doutoramento em Ciências da Saúde, ramo de Ciências Biomédicas, orientada pela Professora Doutora Maria Manuela Monteiro Grazina e co-orientada pelo Professor Doutor Henrique Manuel Paixão dos Santos Girão e pela Professora Doutora Lee-Jun C. Wong e apresentada à Faculdade de Medicina da Universidade de Coimbra Julho 2017 Faculty of Medicine Establishing the pathogenicity of novel mitochondrial DNA sequence variations: a cell and molecular biology approach Mafalda Rita Avó Bacalhau Tese de doutoramento do programa em Ciências da Saúde, ramo de Ciências Biomédicas, realizada sob a orientação científica da Professora Doutora Maria Manuela Monteiro Grazina; e co-orientação do Professor Doutor Henrique Manuel Paixão dos Santos Girão e da Professora Doutora Lee-Jun C. Wong, apresentada à Faculdade de Medicina da Universidade de Coimbra. Julho, 2017 Copyright© Mafalda Bacalhau e Manuela Grazina, 2017 Esta cópia da tese é fornecida na condição de que quem a consulta reconhece que os direitos de autor são pertença do autor da tese e do orientador científico e que nenhuma citação ou informação obtida a partir dela pode ser publicada sem a referência apropriada e autorização. This copy of the thesis has been supplied on the condition that anyone who consults it recognizes that its copyright belongs to its author and scientific supervisor and that no quotation from the -
Targeting MET Dysregulation in Cancer
Published OnlineFirst June 12, 2020; DOI: 10.1158/2159-8290.CD-19-1446 MINI REVIEW Targeting MET Dysregulation in Cancer Gonzalo Recondo 1 , Jianwei Che 2 , 3 , Pasi A. Jänne 1 , 4 , and Mark M. Awad 1 ABSTRACT Aberrant MET signaling can drive tumorigenesis in several cancer types through a variety of molecular mechanisms including MET gene amplifi cation, mutation, rear- rangement, and overexpression. Improvements in biomarker discovery and testing have more recently enabled the selection of patients with MET-dependent cancers for treatment with potent, specifi c, and novel MET-targeting therapies. We review the known oncologic processes that activate MET, discuss therapeutic strategies for MET-dependent malignancies, and highlight emerging challenges in acquired drug resistance in these cancers. signifi cance: Increasing evidence supports the use of MET-targeting therapies in biomarker-selected cancers that harbor molecular alterations in MET. Diverse mechanisms of resistance to MET inhibitors will require the development of novel strategies to delay and overcome drug resistance. INTRODUCTION as plexin–semaphorin–integrin (PSI) and the Ig-like, plexins, transcription factors (IPT) domains ( 9 ). Upon ligand binding, The MET proto-oncogene encodes the tyrosine kinase MET homodimerization results in the phosphorylation of key receptor of HGF and regulates embryogenesis, wound heal- intracellular tyrosine residues at positions Y1234/35 within ing, liver regeneration, angiogenesis, and immunomodula- the kinase domain and Y1349/56 in the -
Associated Palmoplantar Keratoderma
DR ABIGAIL ZIEMAN (Orcid ID : 0000-0001-8236-207X) Article type : Review Article Pathophysiology of pachyonychia congenita-associated palmoplantar keratoderma: New insight into skin epithelial homeostasis and avenues for treatment Authors: A. G. Zieman1 and P. A. Coulombe1,2 # Affiliations: 1Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; 2Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI 48109, USA #Corresponding author: Pierre A. Coulombe, PhD, 3071 Biomedical Sciences Research Building, 109 Zina Pitcher Place, Ann Arbor, MI 48109, USA. Tel: 734-615-7509. Email: [email protected]. Funding Sources: These studies were supported by grant AR044232 issued to P.A.C. from the National Institute of Arthritis, Musculoskeletal and Skin Disease (NIAMS). A.G.Z. received support from grant T32 CA009110 from the National Cancer Institute. Author Manuscript This is the author manuscript accepted for publication and has undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/BJD.18033 This article is protected by copyright. All rights reserved Conflict of interest disclosures: None declared. Bulleted statements: What’s already known about this topic? Pachyonychia congenita is a rare genodermatosis caused by mutations in KRT6A, KRT6B, KRT6C, KRT16, KRT17, which are normally expressed in skin appendages and induced following injury. Individuals with PC present with multiple clinical symptoms that usually include thickened and dystrophic nails, palmoplantar keratoderma (PPK), glandular cysts, and oral leukokeratosis. -
The Genetic Architecture of Carbon Tetrachloride-Induced Liver Fibrosis in Mice
UCLA UCLA Previously Published Works Title The Genetic Architecture of Carbon Tetrachloride-Induced Liver Fibrosis in Mice. Permalink https://escholarship.org/uc/item/40w5d3f6 Journal Cellular and molecular gastroenterology and hepatology, 11(1) ISSN 2352-345X Authors Tuominen, Iina Fuqua, Brie K Pan, Calvin et al. Publication Date 2021 DOI 10.1016/j.jcmgh.2020.08.010 Peer reviewed eScholarship.org Powered by the California Digital Library University of California ORIGINAL RESEARCH The Genetic Architecture of Carbon Tetrachloride-Induced Liver Fibrosis in Mice Iina Tuominen,1,a Brie K. Fuqua,2,a Calvin Pan,2 Nicole Renaud,3 Kevin Wroblewski,1 Mete Civelek,2 Kara Clerkin,1 Ashot Asaryan,1 Sara G. Haroutunian,1 Joseph Loureiro,3 Jason Borawski,3 Guglielmo Roma,4 Judith Knehr,4 Walter Carbone,4 Samuel French,5 Brian W. Parks,2 Simon T. Hui,2 Margarete Mehrabian,2 Clara Magyar,5 Rita M. Cantor,6 Chinweike Ukomadu,3 Aldons J. Lusis,2 and Simon W. Beaven1 1Department of Medicine, Vatche and Tamar Manoukian Division of Digestive Diseases at UCLA and Pfleger Liver Institute, David Geffen School of Medicine at UCLA, Los Angeles, California; 2Departments of Medicine, Microbiology and Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, California; 3Novartis Institutes for Biomedical Research, Cambridge, Massachusetts; 4Novartis Pharma AG, Basel, Switzerland; 5Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California; and 6Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, California 1234100 Strain ….. GWAS Fibrosis ….. Correlation Transcripts Modeling SUMMARY were euthanized for liver histology and gene expression. -
A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated. -
Detailed Analysis of Focal Chromosome Arm 1Q
Detailed Analysis of Focal Chromosome Arm 1q and 6p Amplifications in Urothelial Carcinoma Reveals Complex Genomic Events on 1q, and SOX4 as a Possible Auxiliary Target on 6p. Eriksson, Pontus; Aine, Mattias; Sjödahl, Gottfrid; Staaf, Johan; Lindgren, David; Höglund, Mattias Published in: PLoS ONE DOI: 10.1371/journal.pone.0067222 2013 Link to publication Citation for published version (APA): Eriksson, P., Aine, M., Sjödahl, G., Staaf, J., Lindgren, D., & Höglund, M. (2013). Detailed Analysis of Focal Chromosome Arm 1q and 6p Amplifications in Urothelial Carcinoma Reveals Complex Genomic Events on 1q, and SOX4 as a Possible Auxiliary Target on 6p. PLoS ONE, 8(6), [e67222]. https://doi.org/10.1371/journal.pone.0067222 Total number of authors: 6 General rights Unless other specific re-use rights are stated the following general rights apply: Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal Read more about Creative commons licenses: https://creativecommons.org/licenses/ Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. -
Downloaded from JASPAR (JASPAR ID: MA0527.1) Across All Identified Peaks Using the Matrix-Scan Module from RSAT [20]
bioRxiv preprint doi: https://doi.org/10.1101/585653; this version posted March 24, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. ZBTB33 (Kaiso) methylated binding sites are associated with primed heterochromatin Quy Xiao Xuan Lin1, Khadija Rebbani1, Sudhakar Jha1,2, Touati Benoukraf1,3* 1Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore 2Department of Biochemistry, National University of Singapore, Singapore, Singapore 3Discipline of Genetics, Faculty of Medicine, Memorial University of Newfoundland, St. John’s, NL, Canada *Correspondence to: Touati Benoukraf, Ph.D. Faculty of Medicine, Discipline of Genetics Cancer Science Institute of Singapore Craig L. Dobbin Genetics Research Centre National University of Singapore Room 5M317 Centre for Translational Medicine, Memorial University of Newfoundland 14 Medical Drive, #12-01 St. John's, NL A1B 3V6 Singapore 117599 Canada Phone: +1 (709) 864-6671 Email: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/585653; this version posted March 24, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract Background: ZBTB33, also known as Kaiso, is a member of the zinc finger and BTB/POZ family. In contrast to many transcription factors, ZBTB33 has the ability to bind both a sequence-specific consensus and methylated DNA. -
Accompanies CD8 T Cell Effector Function Global DNA Methylation
Global DNA Methylation Remodeling Accompanies CD8 T Cell Effector Function Christopher D. Scharer, Benjamin G. Barwick, Benjamin A. Youngblood, Rafi Ahmed and Jeremy M. Boss This information is current as of October 1, 2021. J Immunol 2013; 191:3419-3429; Prepublished online 16 August 2013; doi: 10.4049/jimmunol.1301395 http://www.jimmunol.org/content/191/6/3419 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2013/08/20/jimmunol.130139 Material 5.DC1 References This article cites 81 articles, 25 of which you can access for free at: http://www.jimmunol.org/content/191/6/3419.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on October 1, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Global DNA Methylation Remodeling Accompanies CD8 T Cell Effector Function Christopher D. Scharer,* Benjamin G. Barwick,* Benjamin A. Youngblood,*,† Rafi Ahmed,*,† and Jeremy M. -
Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase -
Eight Novel Mutations Confirm the Role of AAGAB in Punctate Palmoplantar Keratoderma Type 1 (Buschke-Fischer-Brauer) and Show Broad Phenotypic Variability
Acta Derm Venereol 2016 Epub ahead of print INVESTIGATIVE REPORT Eight Novel Mutations Confirm the Role of AAGAB in Punctate Palmoplantar Keratoderma Type 1 (Buschke-Fischer-Brauer) and Show Broad Phenotypic Variability Kathrin A. GIEHL1,2, Thomas HERZINGER2, Hans WOLFF1,2, Miklós SÁRDY1,2, Tanja VON BRAUNMÜHL2, Valérie DEKEULE- NEER3, Yves SZNAJER4, Dominique TENNSTEDT3, Pascaline BOES4, Stefan RAPPRICH5, Nicola WAGNER5, Regina C. BETZ6, Markus BRAUN-FALCO2, Tim STROM7, Thomas RUZICKA2 and Gertrud N. ECKSTEIN7 1Center for Rare and Genetic Skin Diseases, Department of Dermatology, 2Department of Dermatology, Ludwig-Maximilian University, Munich, Ger- many, 3Department of Dermatology, 4Center for Human Genetics, Cliniques Universitaires St Luc, UCL, Brussels, Belgium, 5Department of Dermatology, Klinikum Darmstadt, Darmstadt, 6Institute of Human Genetics, University of Bonn, Bonn, and 7Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany Punctate palmoplantar keratoderma (PPKP1; Buschke- to the mostly diffuse hyperkeratinization observed in other Fischer-Brauer) is a rare autosomal dominant inherited palmoplantar keratodermas (6, 7). In mechanically irritated skin disease characterized by multiple hyperkeratotic areas, confluent plaques can be found. The lesions usually papules involving the palms and soles. Mutations have develop in early adolescence, but can also occur later in been found at 2 loci, on chromosomes 15q22–15q24 and life (5). The incidence of PPKP1 has not been extensively 8q24.13–8q24.21. We recently identified mutations in 3 evaluated, but has been estimated at 1.17 per 100,000 in- families, in the AAGAB gene on 15q, which encodes the habitants in Croatia (8). There have been reports in which alpha- and gamma-adaptin-binding protein p34.